| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 10/07/2009 | EP1874285B1 Complementary compositions to reduce blood glucose levels and treat diabetes |
| 10/07/2009 | EP1650182B1 Branched carboxylic acid compound and use thereof |
| 10/07/2009 | EP1617216B1 Novel method of screening |
| 10/07/2009 | EP1529038B1 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
| 10/07/2009 | EP1434791B1 Specific binding agents of human angiopoietin-2 |
| 10/07/2009 | EP1406682B1 Drug delivery devices |
| 10/07/2009 | EP1385550B1 Therapeutic medicaments for inducing tolerance |
| 10/07/2009 | EP1339413B1 Compositions comprising complexes of phosphate derivatives of tocopherol |
| 10/07/2009 | EP1317285B1 Methods for treating demyelinating diseases |
| 10/07/2009 | EP1191099B1 Novel polypeptide and dna thereof |
| 10/07/2009 | CN101553256A Phenylpropionamide compounds and the use thereof |
| 10/07/2009 | CN101553239A Salivary substitute |
| 10/07/2009 | CN101553223A Combination of an HDAC inhibitor and an antimetabolite |
| 10/07/2009 | CN101553216A Treatment of inflammatory diseases |
| 10/07/2009 | CN101553214A Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy |
| 10/07/2009 | CN101549157A Acidic drug for curing toothache within one second |
| 10/07/2009 | CN101549156A Anhydrous compositions useful for attaining enhanced sexual wellness |
| 10/07/2009 | CN101549153A Composite and method for self-treating tumor |
| 10/07/2009 | CN101548948A Anti-cancer medicine sustained-release agent containing 5-FU potentiating agent |
| 10/07/2009 | CN100547075C Her-2/neu DNA vaccine having anti-cancer activity |
| 10/07/2009 | CN100546656C Kidney-targeted medicine vector and the formed prodrug, preparation method and uses |
| 10/07/2009 | CN100546655C Tablet composition containing Chinese orthodox medicine extract and process for producing the same |
| 10/07/2009 | CN100546653C Time selecting released preparation containing angiotensin II 1 receptor antagonist |
| 10/07/2009 | CN100546581C Combinations comprising anti-epileptic drugs for the treatment of neurological disorders. |
| 10/06/2009 | US7598412 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators |
| 10/06/2009 | US7598355 Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| 10/06/2009 | US7598293 Antidiabetic agents, antilipemic agents, dietetics, anticholesterol agents, hypotensive agents, cardiovascular disorders; (S)-Ethyl 2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl) propylamino}phenyl]propionate |
| 10/06/2009 | US7598288 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma |
| 10/06/2009 | US7598262 Method for treating diabetes |
| 10/06/2009 | US7598050 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein |
| 10/06/2009 | US7598048 Administering a Prokineticin 2 receptor antagonist or agonist; control internal body clock and functions |
| 10/06/2009 | US7597883 Methods for promoting growth of bone, ligament, and cartilage |
| 10/06/2009 | CA2427195C Controlled release metformin compositions |
| 10/06/2009 | CA2399971C Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator |
| 10/06/2009 | CA2381348C Lck-derived peptides activating ctls |
| 10/06/2009 | CA2381323C Amyloid .beta. protein (globular assembly and uses thereof) |
| 10/06/2009 | CA2376596C Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies |
| 10/06/2009 | CA2329350C Topical formulation comprising poloxamers and further microbicides |
| 10/06/2009 | CA2328076C Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor |
| 10/06/2009 | CA2207779C Carcinoma treatment |
| 10/06/2009 | CA2180479C Method for treatment of obesity using prolactin modulators and diet |
| 10/06/2009 | CA2120626C Method for enhancing gut absorption |
| 10/01/2009 | WO2009120296A1 Treatment of psoriasis or psoriatic arthritis using cyclopropyl-n-{2-{(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide |
| 10/01/2009 | WO2009119792A1 GHRELIN AND DERIVATIVE THEREOF, OR THERAPEUTIC AGENT FOR CHRONIC RESPIRATORY TRACT INFECTIONS COMPRISING GROWTH HORMONE SECRETAGOGUE RECEPTOR 1a AGONIST AS ACTIVE INGREDIENT |
| 10/01/2009 | WO2009119652A1 USE OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND TNF α INHIBITOR IN COMBINATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE OR SALT THEREOF AND THE INHIBITOR |
| 10/01/2009 | WO2009119554A1 Promoter for bicarbonate secretion in gastrointestinal tract |
| 10/01/2009 | WO2009119167A1 Aniline derivative having anti-rna viral activity |
| 10/01/2009 | WO2009118324A1 5imidazoquinolines and pyrimidine derivatives as potent modulators of vegf-driven angiogenic processes |
| 10/01/2009 | WO2009118191A2 Therapy for vitiligo |
| 10/01/2009 | WO2009095454A3 Method for the identification of patients in need of therapy having minor cognitive disorders and the treatment of such patients |
| 10/01/2009 | WO2009090556A8 Artificial reproduction of pharmaceutical conditions of dependency to tobacco and other addictive drugs (opiacea, psychostimulants, alcohol) by combination of nicotine and a ligand (agonist or 5 antagonist) of 5-ht1a receptors |
| 10/01/2009 | WO2007127377A8 Combinations comprising omega-3 fatty acid compounds for the treatment of cardiovascular disease |
| 10/01/2009 | US20090249519 Immunization of fish with plant-expressed recombinant proteins |
| 10/01/2009 | US20090249502 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer; antibody or antigen-binding fragment thereof that specifically binds to a 193P1E1B protein; drug delivery |
| 10/01/2009 | US20090247778 Star polymer such as of a polylactone based on a central phosphorus atom derived from phosphorus oxychloride (POCl3) or ethyl dichlorophosphate; biodegradable and/or biocompatible; sustained release drug delivery; reverse thermal gelation |
| 10/01/2009 | US20090247632 Dermatological compositions and methods |
| 10/01/2009 | US20090247584 Phenoxy-piperidines for the treatment of diseases such as schizophrenia and depression |
| 10/01/2009 | US20090247558 Use of the crh (corticotropin releasing hormone) - ucn (urocortin) system in the treatment of inflammatory diseases |
| 10/01/2009 | US20090247528 Method of treating attention deficit disorder |
| 10/01/2009 | US20090247510 Use Of Irbesartan For The Preparation Of Medicinal Products That Are Useful For Preventing or Treating Pulmonary Hypertension |
| 10/01/2009 | US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders |
| 10/01/2009 | US20090247487 Combination Therapy to Treat Hepatitis B Virus |
| 10/01/2009 | US20090247479 Therapeutic Use of Methionine to Reduce the Toxicity of Aminoglycoside Antibiotics |
| 10/01/2009 | US20090247452 comprising ziconotide, methionine and hydromorphone for producing analgesia in a mammalian subject; reduces the side effects, no drug interactions |
| 10/01/2009 | US20090246254 Non-hormonal vaginal contraceptive |
| 10/01/2009 | US20090246232 Pharmaceutical composition |
| 10/01/2009 | US20090246209 Gnrh analogues for treatment of urinary incontinence |
| 10/01/2009 | US20090246201 Substances |
| 10/01/2009 | US20090246173 Treatment with anti-vegf antibodies |
| 10/01/2009 | US20090246172 Compositions comprising epothilones and their use for the treatment of carcinoid syndrome |
| 10/01/2009 | US20090246167 Stimuli-responsive systems for controlled drug delivery |
| 10/01/2009 | US20090246148 Medicinal aerosols and methods of delivery thereof |
| 10/01/2009 | US20090246147 Delivery Of Antipsychotics Through An Inhalation Route |
| 10/01/2009 | CA2719707A1 Therapy for vitiligo |
| 10/01/2009 | CA2719290A1 Use of benzophenone derivative or salt thereof and tnf.alpha. inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor |
| 10/01/2009 | CA2718412A1 Treatment of psoriasis or psoriatic arthritis using cyclopropyl-n-{2-{(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide |
| 10/01/2009 | CA2717948A1 5imidazoquinolines and pyrimidine derivatives as potent modulators of vegf-driven angiogenic processes |
| 10/01/2009 | CA2710983A1 Lipid nanoparticle compositions and methods of making and using the same |
| 09/30/2009 | EP2105502A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/30/2009 | EP2105449A2 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 09/30/2009 | EP2105143A1 Pharmaceutical compositions based on salts of tiotropium and ciclesonide |
| 09/30/2009 | EP2105141A1 Short bioactive peptides and methods for their use |
| 09/30/2009 | EP2105136A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2105135A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2104534A1 New combination for use in the treatment of inflammatory disorders |
| 09/30/2009 | EP2104499A1 Method and composition for reducing reperfusion injury |
| 09/30/2009 | EP1739186B1 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelerator and apoptosis inhibitor |
| 09/30/2009 | EP1389122B1 Prevention of epithelial cancer |
| 09/30/2009 | EP1349549B1 Novel medicament compositions based on salts of tiotropium and on ciclesonide |
| 09/30/2009 | EP1309627B1 Immunotherapy for chronic myelocytic leukemia with naked anti-nca-90 antibody |
| 09/30/2009 | EP1286689B1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 09/30/2009 | EP1261347B1 Therapeutic compositions and methods for treating periodontitis with antiinflamatory compounds |
| 09/30/2009 | EP1242122B1 Delivery of proteins across polar epithelial cell layers |
| 09/30/2009 | EP1037649B1 Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| 09/30/2009 | CN101543632A Anti-tumor prodrug having accurate structure and taking novel amphipathic polymer as carrier and synthetic method thereof |
| 09/30/2009 | CN101543631A Microspherical substrate containing beeswax, pharmaceutical composition containing microspherical substrate and application thereof |
| 09/30/2009 | CN101543628A Medicament and preparation thereof for treating hyperlipemia and atherosclerosis |
| 09/30/2009 | CN101543507A Immunostimulatory nucleic acids |
| 09/30/2009 | CN101543497A Methods of treating patients suffering from movement disorders |
| 09/30/2009 | CN100545174C Compositions and methods for wt1 specific immunotherapy |